Itamar David is CFO at Enox Biopharma Inc (NONE). They have made 1 open-market trade across 1 company since 2010, most recently 2010-11-04.
CIK 0001454396
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $171K since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 324,361 | — |
Shares reported on the most recent Form 4, priced at the 2010-11-05 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PrivateEnox Biopharma Inc | BUY | 2010-11-04 | 2010-11-05 | $0.30 | $60K | N/A | N/A | N/A |
| PrivateEnox Biopharma Inc | BUY | 2010-07-15 | 2010-08-18 | $0.49 | $110K | N/A | N/A | N/A |